NG, KIU YAN CHARLOTTE
 Distribuzione geografica
Continente #
NA - Nord America 3.102
AS - Asia 3.052
SA - Sud America 604
EU - Europa 497
Continente sconosciuto - Info sul continente non disponibili 168
AF - Africa 72
OC - Oceania 8
Totale 7.503
Nazione #
US - Stati Uniti d'America 2.985
SG - Singapore 1.782
CN - Cina 610
BR - Brasile 498
VN - Vietnam 258
IT - Italia 188
HK - Hong Kong 149
GB - Regno Unito 61
DE - Germania 53
CA - Canada 49
IN - India 49
BD - Bangladesh 41
FR - Francia 38
MX - Messico 38
AR - Argentina 36
RU - Federazione Russa 27
TR - Turchia 23
ZA - Sudafrica 22
EC - Ecuador 21
VE - Venezuela 21
PL - Polonia 20
IQ - Iraq 19
FI - Finlandia 16
NL - Olanda 16
UZ - Uzbekistan 14
MY - Malesia 13
IE - Irlanda 12
JP - Giappone 12
SA - Arabia Saudita 12
PK - Pakistan 11
CL - Cile 10
ES - Italia 10
PH - Filippine 10
KE - Kenya 9
CR - Costa Rica 8
MA - Marocco 8
SE - Svezia 8
UA - Ucraina 8
CZ - Repubblica Ceca 7
ID - Indonesia 7
NG - Nigeria 7
AU - Australia 6
DZ - Algeria 6
AE - Emirati Arabi Uniti 5
CO - Colombia 5
HN - Honduras 5
LB - Libano 5
LV - Lettonia 5
PY - Paraguay 5
AM - Armenia 4
AZ - Azerbaigian 4
BO - Bolivia 4
JM - Giamaica 4
NP - Nepal 4
TN - Tunisia 4
BE - Belgio 3
EG - Egitto 3
ET - Etiopia 3
IL - Israele 3
KG - Kirghizistan 3
LT - Lituania 3
LU - Lussemburgo 3
NI - Nicaragua 3
RO - Romania 3
SN - Senegal 3
AL - Albania 2
BG - Bulgaria 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
JO - Giordania 2
MG - Madagascar 2
PE - Perù 2
SV - El Salvador 2
TH - Thailandia 2
UY - Uruguay 2
AO - Angola 1
AT - Austria 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BT - Bhutan 1
BY - Bielorussia 1
CD - Congo 1
CH - Svizzera 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
GI - Gibilterra 1
GR - Grecia 1
KR - Corea 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MD - Moldavia 1
MK - Macedonia 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
Totale 7.328
Città #
Singapore 735
San Jose 518
Ashburn 445
The Dalles 291
New York 272
Shanghai 248
Council Bluffs 173
Dallas 172
Beijing 168
Hong Kong 145
Los Angeles 116
Santa Clara 111
Ho Chi Minh City 95
Milan 77
Buffalo 59
Hanoi 57
São Paulo 45
Boardman 37
Wilmington 28
San Mateo 21
Orem 20
Rome 20
Brooklyn 18
Chennai 18
Johannesburg 18
Mexico City 17
Warsaw 17
Chicago 16
Da Nang 15
Frankfurt am Main 15
Munich 15
Phoenix 15
Rio de Janeiro 15
Seattle 15
Helsinki 14
Tashkent 14
Toronto 14
Tokyo 12
Paris 11
Atlanta 10
Belo Horizonte 10
London 10
Boston 9
Brasília 9
Charlotte 9
Denver 9
Figino 9
Guayaquil 9
Kuala Lumpur 9
Princeton 9
San Francisco 9
Abbiategrasso 8
Ankara 8
Dublin 8
Fortaleza 8
Haiphong 8
Lissone 8
Manchester 8
Nairobi 8
Lawrence 7
San José 7
Amsterdam 6
Baghdad 6
Brno 6
Buenos Aires 6
Campinas 6
Chandler 6
Dhaka 6
Erbil 6
Fairfield 6
Goiânia 6
Guarulhos 6
Houston 6
Hải Dương 6
Naples 6
Sydney 6
Benin City 5
Curitiba 5
Istanbul 5
Maracaibo 5
Montreal 5
Moscow 5
Pasadena 5
Piscataway 5
Poplar 5
Porto Alegre 5
Quito 5
Recife 5
Riga 5
Riyadh 5
Salvador 5
Stockholm 5
Assago 4
Biên Hòa 4
Casablanca 4
Colombo 4
Hangzhou 4
Jeddah 4
Joinville 4
Las Vegas 4
Totale 4.503
Nome #
High expression of HOXA13 correlates with poorly differentiated hepatocellular carcinomas and modulates sorafenib response in in vitro models 98
Molecular classification of hepatocellular carcinoma: The view from metabolic zonation 79
Organoid Models of Human Liver Cancers Derived from Tumor Needle Biopsies 78
Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: A proof-of-principle 75
Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast 74
Circulating Cell-Free DNA Captures the Intratumor Heterogeneity in Multinodular Hepatocellular Carcinoma 74
PI3K inhibition circumvents resistance to SHP2 blockade in metastatic triple-negative breast cancer 74
A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT) 73
Adenylosuccinate lyase is oncogenic in colorectal cancer by causing mitochondrial dysfunction and independent activation of NRF2 and mTOR-MYC-axis 71
A tumor DNA complex aberration index is an independent predictor of survival in breast and ovarian cancer 70
A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations 69
Metaplastic breast carcinoma: more than a special type 67
Genetic profiling using plasma-derived cell-free DNA in therapy-naive hepatocellular carcinoma patients: A pilot study 66
Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma 65
Cancer Diagnosis Using a Liquid Biopsy: Challenges and Expectations 65
Prognostic signatures in breast cancer: correlation does not imply causation 64
Response to dual HER2 blockade in a patient with HER3-mutant metastatic breast cancer 64
The Genomic Landscape of Male Breast Cancers 64
Breast cancer intratumor genetic heterogeneity: causes and implications 63
Alterations in Homologous Recombination Repair Genes in Prostate Cancer Brain Metastases 63
APOBEC mutagenesis, kataegis, chromothripsis in EGFR-mutant osimertinib-resistant lung adenocarcinomas 62
Breast cancer intra-tumor heterogeneity 62
Combining two antibodies to define E-cadherin loss of expression in non-lobular breast carcinomas: when less is more 62
Genomic landscape of adenoid cystic carcinoma of the breast 62
The protein histidine phosphatase LHPP is a tumour suppressor 62
Bi-allelic alterations in DNA repair genes underpin homologous recombination DNA repair defects in breast cancer 61
Integrative genomic and transcriptomic characterization of papillary carcinomas of the breast 60
Circulating Cell-Free DNA in Hepatocellular Carcinoma: Current Insights and Outlook 57
Comprehensive clinical and molecular analyses of neuroendocrine carcinomas of the breast 57
Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer 56
Genomic characterization of metastatic breast cancers 56
Genetic Alterations in Benign Breast Biopsies of Subsequent Breast Cancer Patients 56
Hepatocellular Carcinoma Immune Microenvironment Analysis: A Comprehensive Assessment with Computational and Classical Pathology 56
The Genomic Landscape of Serrated Lesion of the Colorectum: Similarities and Differences With Tubular and Tubulovillous Adenomas 56
Genetic Heterogeneity in Therapy-Naïve Synchronous Primary Breast Cancers and Their Metastases 56
Standardizing Patient-Derived Organoid Generation Workflow to Avoid Microbial Contamination From Colorectal Cancer Tissues 56
Proteasome Addiction Defined in Ewing Sarcoma Is Effectively Targeted by a Novel Class of 19S Proteasome Inhibitors 55
Structural analysis of the genome of breast cancer cell line ZR-75-30 identifies twelve expressed fusion genes 55
The Landscape of Somatic Genetic Alterations in Metaplastic Breast Carcinomas 55
Genomic Analysis Revealed New Oncogenic Signatures in TP53-Mutant Hepatocellular Carcinoma 55
SCIM: universal single-cell matching with unpaired feature sets 55
ESR1 and endocrine therapy resistance: more than just mutations 55
Benchmarking mutation effect prediction algorithms using functionally validated cancer-related missense mutations 55
HER2 Reactivation through Acquisition of the HER2 L755S Mutation as a Mechanism of Acquired Resistance to HER2-targeted Therapy in HER2(+) Breast Cancer 54
Phosphoprotein enriched in diabetes (PED/PEA15) promotes migration in hepatocellular carcinoma and confers resistance to sorafenib 54
Massively parallel sequencing analysis of synchronous fibroepithelial lesions supports the concept of progression from fibroadenoma to phyllodes tumor 54
Massively parallel sequencing of phyllodes tumours of the breast reveals actionable mutations, and TERT promoter hotspot mutations and TERT gene amplification as likely drivers of progression 54
Chromosomal instability determines taxane response 53
NGS-pipe: a flexible, easily extendable and highly configurable framework for NGS analysis 53
Hepatocellular Carcinoma Xenografts Established From Needle Biopsies Preserve the Characteristics of the Originating Tumors 53
Predictive performance of microarray gene signatures: impact of tumor heterogeneity and multiple mechanisms of drug resistance 53
Discovery of synthetic lethal interactions from large-scale pan-cancer perturbation screens 53
Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma 52
Patient-derived xenografts and organoids model therapy response in prostate cancer 52
Vascular endothelial growth factor A amplification in colorectal cancer is associated with reduced M1 and M2 macrophages and diminished PD-1-expressing lymphocytes 52
Diagnostic Targeted Sequencing Panel for Hepatocellular Carcinoma Genomic Screening 52
PipeIT2: A tumor-only somatic variant calling workflow for molecular diagnostic Ion Torrent sequencing data 52
Pregnancy at early age is associated with a reduction of progesterone-responsive cells and epithelial Wnt signaling in human breast tissue 51
Transcriptional Enhancer Factor Domain Family member 4 Exerts an Oncogenic Role in Hepatocellular Carcinoma by Hippo-Independent Regulation of Heat Shock Protein 70 Family Members 51
Interferon lambda 4 impairs hepatitis C viral antigen presentation and attenuates T cell responses 51
The Role of Long Non-Coding RNAs in Hepatocarcinogenesis 51
The Tumor Profiler Study: integrated, multi-omic, functional tumor profiling for clinical decision support 51
Genomic profiling of histological special types of breast cancer 51
PipeIT: A Singularity Container for Molecular Diagnostic Somatic Variant Calling on the Ion Torrent Next-Generation Sequencing Platform 51
Detection of isoforms and genomic alterations by high-throughput full-length single-cell RNA sequencing in ovarian cancer 51
Are acinic cell carcinomas of the breast and salivary glands distinct diseases? 50
PIKing the type and pattern of PI3K pathway mutations in endometrioid endometrial carcinomas 50
Tandem duplication of chromosomal segments is common in ovarian and breast cancer genomes 50
Phyllodes tumors with and without fibroadenoma-like areas display distinct genomic features and may evolve through distinct pathways 50
Resolving quandaries: basaloid adenoid cystic carcinoma or breast cylindroma? The role of massively parallel sequencing 49
RNASeq analysis reveals biological processes governing the clinical behaviour of endometrioid and serous endometrial cancers 49
High-resolution genomic profiling of thyroid lesions uncovers preferential copy number gains affecting mitochondrial biogenesis loci in the oncocytic variants 49
Contralateral breast cancers: Independent cancers or metastases? 48
Spatial and temporal heterogeneity in high-grade serous ovarian cancer: a phylogenetic analysis 48
Targeted capture massively parallel sequencing analysis of LCIS and invasive lobular cancer: Repertoire of somatic genetic alterations and clonal relationships 48
Stroma Transcriptomic and Proteomic Profile of Prostate Cancer Metastasis Xenograft Models Reveals Prognostic Value of Stroma Signatures 48
Multi-omics data integration reveals novel drug targets in hepatocellular carcinoma 48
PI3K pathway activation in high-grade ductal carcinoma in situ--implications for progression to invasive breast carcinoma 48
Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands 48
Breast cancer genomics from microarrays to massively parallel sequencing: paradigms and new insights 48
Deciphering the clonal relationship between glandular and squamous components in adenosquamous carcinoma of the lung using whole exome sequencing 47
The role of tandem duplicator phenotype in tumour evolution in high-grade serous ovarian cancer 47
Metaplastic breast carcinomas display genomic and transcriptomic heterogeneity [corrected] 47
Genetic events in the progression of adenoid cystic carcinoma of the breast to high-grade triple-negative breast cancer 46
The repertoire of somatic genetic alterations of acinic cell carcinomas of the breast: an exploratory, hypothesis-generating study 46
Epigenetic priming in chronic liver disease impacts the transcriptional and genetic landscapes of hepatocellular carcinoma 46
Infiltration by IL22-Producing T Cells Promotes Neutrophil Recruitment and Predicts Favorable Clinical Outcome in Human Colorectal Cancer 46
SF3B1 mutations constitute a novel therapeutic target in breast cancer 46
Diverse BRCA1 and BRCA2 Reversion Mutations in Circulating Cell-Free DNA of Therapy-Resistant Breast or Ovarian Cancer 46
HMGA1 Expression in Human Hepatocellular Carcinoma Correlates with Poor Prognosis and Promotes Tumor Growth and Migration in in vitro Models 46
Expression of RET is associated with Oestrogen receptor expression but lacks prognostic significance in breast cancer 46
Establishing the origin of metastatic deposits in the setting of multiple primary malignancies: the role of massively parallel sequencing 46
Genetic alterations of triple negative breast cancer by targeted next-generation sequencing and correlation with tumor morphology 46
Genetic heterogeneity and actionable mutations in HER2-positive primary breast cancers and their brain metastases 46
Microglandular adenosis associated with triple-negative breast cancer is a neoplastic lesion of triple-negative phenotype harbouring TP53 somatic mutations 46
The Role of Chronic Liver Diseases in the Emergence and Recurrence of Hepatocellular Carcinoma: An Omics Perspective 45
Nectin-4 Expression Is an Independent Prognostic Biomarker and Associated With Better Survival in Triple-Negative Breast Cancer 45
Progression from ductal carcinoma in situ to invasive breast cancer: revisited 45
Integrative proteogenomic characterization of hepatocellular carcinoma across etiologies and stages 45
Discovery of heterozygous KRT10 alterations in MAUIE cases underlines the importance of regular skin cancer screening in ichthyosis with confetti 44
Totale 5.535
Categoria #
all - tutte 44.187
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.187


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202232 0 0 0 10 0 0 0 7 1 1 5 8
2022/202344 14 0 7 1 4 1 0 3 5 7 2 0
2023/2024767 1 4 5 2 0 339 54 56 14 10 112 170
2024/20251.506 27 5 8 22 11 173 88 96 320 429 160 167
2025/20264.599 629 384 170 386 123 250 1.210 217 182 341 340 367
2026/2027498 232 266 0 0 0 0 0 0 0 0 0 0
Totale 7.503